ACHROMATOPSIA 7

Clinical trials for ACHROMATOPSIA 7 explained in plain language.

Never miss a new study

Get alerted when new ACHROMATOPSIA 7 trials appear

Sign up with your email to follow new studies for ACHROMATOPSIA 7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

FDA-Approved drug tested to restore vision in genetic color blindness

Disease control Terminated

This early-stage study is testing whether an existing drug called glycerol phenylbutyrate (PBA) can improve vision in people with a rare, inherited form of color blindness caused by a specific gene mutation (ATF6). Two adult patients will take the drug three times a day and have …

Matched conditions: ACHROMATOPSIA 7

Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

ACHROMATOPSIA 7

Get alerted when new ACHROMATOPSIA 7 trials appear

FDA-Approved drug tested to restore vision in genetic color blindness